John T. Schiller

from Wikipedia, the free encyclopedia

John Todd Schiller (born January 1, 1953 in Madison , Wisconsin ) is an American microbiologist , virologist and molecular biologist .

John Schiller graduated from the University of Wisconsin at Madison with a bachelor's degree in molecular biology in 1975 and received a PhD in microbiology from the University of Washington in 1982 . His dissertation was entitled Relationship of Plasmids from Corynebacterium diphtheriae and aerobic skin Coryneforms . He then worked at the Laboratory of Cellular Oncology at the National Institutes of Health (NIH), initially as a postdoctoral fellow , becoming a Senior Staff Fellow in 1986 and Senior Investigator in 1992 . From 1998 he headed the Neoplastic Diseases Department, in 2000 he became Deputy Laboratory Director and in 2016 Distinguished Investigator of the NIH.

He is known for researching the molecular biology of the human papillomavirus (HPV) and developing a vaccine for prophylaxis against it with Douglas R. Lowy . This resulted in the commercial vaccines Cervarix and Gardasil. His laboratory is also developing methods for developing therapies against cancer with the help of the capsids of the HPV, as these have a preference for binding to tumor cells.

In 2017 he and Douglas R. Lowy received the Lasker ~ DeBakey Clinical Medical Research Award and the Joseph Public Health Award of the American Society for Microbiology , and in 2018 the Szent-Györgyi Prize . In 2011 he received the Albert Sabine Gold Medal, in 2007 the Service to America Medal (Federal Employee of the Year) and in 2014 (for 2012) the National Medal of Technology and Innovation . In 2020 Schiller was elected to the National Academy of Sciences .

Web links

  1. a b John Schiller, 2012 National Medal of Technology and Innovation. In: nationalmedals.org. January 2, 2017, accessed September 6, 2017 .